Zenas BioPharma, Inc. (ZBIO)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Zenas BioPharma, Inc.’s names, not what it holds today.
5 published
1 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Dec 18, 2025 | 2025/0382366 | METHODS OF PRODUCING ANTI-CD19 ANTIBODIES | Biotechnology | Zenas BioPharma, Inc. |
| Sep 11, 2025 | 2025/0281608 | STABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOF | Pharmaceuticals | Zenas BioPharma, Inc. |
| Jul 17, 2025 | 2025/0230238 | METHODS AND COMPOSITIONS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOUS (SLE) | Pharmaceuticals | Zenas BioPharma, Inc. |
| Jul 10, 2025 | 2025/0223356 | METHODS AND COMPOSITIONS FOR TREATING RELAPSING MULTIPLE SCLEROSIS | Pharmaceuticals | Zenas BioPharma, Inc. |
| Apr 24, 2025 | 2025/0129157 | METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS | Pharmaceuticals | Zenas BioPharma, Inc. |
| Mar 13, 2025 | 2025/0084167 | METHODS AND COMPOSITIONS FOR TREATING IgG4-RELATED DISEASES | Pharmaceuticals | Zenas BioPharma, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.